ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IKA Ilika Plc

29.00
-0.50 (-1.69%)
Last Updated: 08:00:15
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.69% 29.00 28.00 30.00 29.00 29.00 29.00 79,631 08:00:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 702k -7.3M -0.0459 -6.32 46.1M

Ilika plc Update on fuel cell catalyst patent in Europe (9123V)

13/08/2015 7:01am

UK Regulatory


Ilika (LSE:IKA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Ilika Charts.

TIDMIKA

RNS Number : 9123V

Ilika plc

13 August 2015

13 August 2015

Ilika plc

("Ilika" or the "Company")

Update on fuel cell catalyst patent in Europe

Ilika (AIM: IKA), the accelerated materials innovation company, announces that the European Patent Office (EPO) has upheld Ilika's opposition to a fuel cell catalyst patent from Brookhaven Science Associates (BSA).

Certain claims of a granted European patent from Brookhaven Science Associates (BSA) might have impacted upon Ilika's freedom to operate its own granted European patent. BSA manages Brookhaven National Laboratory (BNL) on behalf of the United States Department of Energy (US DOE). BNL is a US national laboratory located in Upton, New York, on Long Island, primarily funded by the Office of Science of the US DOE.

Ilika had therefore filed an Opposition against the BSA patent in February 2013, and oral proceedings took place before the Opposition Division on 17th March 2015 at the European Patent Office (EPO) in Rijswijk, Netherlands. As a result of these proceedings, the BSA European patent was revoked. The EPO issued a notice on 8th August 2015 that the opposition proceedings were now terminated with revocation of the patent as the time limit had expired for filing an appeal against the decision to revoke the patent.

Ilika's patents underpin the product development work, which was supported by the Carbon Trust through the GBP150,000 equity investment Ilika announced in September 2012. The Carbon Trust invested in Ilika through its Polymer Fuel Cells Challenge programme to support the commercialization of Ilika's high performing electro-catalysts for use in fuel cell vehicles. As part of the Carbon Trust's technical and commercial evaluation of the technology, Ilika submitted performance data for assessment by independent experts demonstrating the performance and stability of the catalyst. The performance data was generated in industry standard tests of membrane electrode assemblies (MEA's) carried out at an independent fuel cell testing facility.

In December 2013, Ilika announced it had submitted positive cell performance data along with material samples for evaluation to three global OEM's. Initial trials were carried out by these OEM's in 2014 and Ilika continues to support evaluation trials by these three and other OEM's. The adoption rate of fuel cell technology has been historically difficult to predict and at present there is only a limited number of vehicles powered by fuel cells on the UK market. However, the first production Toyota Mirai models landed in Europe this week ahead of the official launch in September. The limited number of cars available in Britain is already sold out. The launch of this vehicle signals an increased focus by OEM's on cost-reduction of fuel cell technology with a view to enabling the mass market.

Commenting on this latest development, Graeme Purdy, Ilika CEO, said: "Ilika invests significantly in creating valuable intellectual property to underpin the growth of its business. Potentially competitive filings are monitored very closely and are challenged where appropriate. We welcome this development as we now enjoy freedom to operate our European patent in addition to our United States patent where there had never been such issues because of the different claims structures between the granted US patents of both BSA and Ilika. This positive outcome supports Ilika's commercialisation activities with interested OEM's."

For more information contact:

 
 Ilika plc                                                                                               www.ilika.com 
 Graeme Purdy, Chief Executive                                                                      Tel: 023 8011 1400 
 Steve Boydell, Finance Director 
 
 Numis Securities Limited                                                                           Tel: 020 7260 1000 
 Oliver Cardigan/ Adrian Trimmings 
  / 
 James Black 
 
 Walbrook PR Ltd                                                             Tel: 020 7933 8780 / ilika@walbrookpr.com 
 Lianne Cawthorne (Media Enquiries)                                                                 Mob: 07584 391 303 
 Paul Cornelius (Investor Enquiries)                                                                        Mob: 07827 
                                                                                                                879460 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLFFFFTLIFLIE

1 Year Ilika Chart

1 Year Ilika Chart

1 Month Ilika Chart

1 Month Ilika Chart

Your Recent History

Delayed Upgrade Clock